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Abstract.  During myogenesis myoblasts fuse to form 
multinucleate cells that express muscle-specific pro- 
teins.  A  specific cell-cell adhesion process precedes 
lipid bilayer union during myoblast fusion (Knudsen, 
K. A., and A.  E  Horwitz.  1977. Dev.  Biol. 
58:328-338) and is mediated by cell surface glycopro- 
teins (Knudsen,  K.  A.,  1985. J.  Cell Biol. 
101:891-897).  In this paper we show that myoblast 
adhesion and myotube formation are inhibited by treat- 
ing fusion-competent myoblasts with phosphatidylino- 
sitol-specific phospholipase C  (PI-PLC). The effect of 
PI-PLC on myoblast adhesion is dose dependent and 
inhibited by D-myo-inositol 1-m¢.nophosphate  and the 
effect on myotube formation is reversible,  suggesting a 
specific, nontoxic effect on myogenesis by the enzyme. 
A  soluble form of adhesion-related glycoproteins is 
released from fusion-competent myoblasts by treatment 
with PI-PLC as evidenced by (a) the ability of phos- 
pholipase C  (PLC)-released material to block the 
adhesion-perturbing  activity of a polyclonal antiserum 
to intact myoblasts; and (b) the ability of PLC-released 
glycoprotein to stimulate adhesion-perturbing  antisera 
when injected into mice.  PI-PLC treatment of fusion- 
competent myoblasts releases an isoform of N-CAM 
into the supernate,  suggesting that N-CAM may par- 
ticipate in mediating myoblast interaction during myo- 
genesis. 
T 
HE formation of mature skeletal  muscle involves the 
fusion of single muscle precursor cells (myoblasts) to 
generate  multinucleate  syncytia  (myotubes) (for re- 
views see Bischoff,  1978; Wakelam,  1985).  In vitro, lipid 
bilayer union of the myoblasts is preceded by a specific cell- 
cell adhesion  step that  is necessary,  but not sufficient,  for 
myoblast fusion (Knudsen  and Horwitz, 1977, 1978). Myo- 
blast adhesion, like the adhesion of other cells types (Takei- 
chi,  1977; Urushihara et al.,  1977; Grunwald et al.,  1980; 
Magnani et al., 1981; Thomas and Steinberg,  1981; Bracken- 
bury et al.,  1981; for review see Damsky et al.,  1984), ap- 
pears to include both Ca++-independent and Ca++-dependent 
molecular mechanisms (Gibralter  and Turner,  1985; Pizzey 
et al., 1988). While myoblast adhesion can occur in the ab- 
sence of Ca  ~, fusion of myoblasts to form myotubes is de- 
pendent upon the presence of Ca  ~  (Shainberg et al.,  1969). 
Previously, we showed that myoblast adhesion is mediated 
by cell surface glycoproteins and that the glycoproteins  in- 
volved in Ca÷÷-dependent adhesion  appear to have a Ca  ÷÷- 
dependent conformation (Knudsen,  1985).  In this  respect 
myoblast adhesion appears similar  to other Ca÷÷-dependent 
cell-cell adhesion  systems (for reviews see Damsky et al., 
1984; Takeichi,  1988) mediated by molecules such as uvo- 
morulin (Hyafil et al.,  1980, 1981; Vestweber and Kemler, 
1985;  Ringwald  et al.,  1987),  L-CAM (Bertolotti  et al., 
1980; Gallin et al., 1983, 1985, 1987), GP 120/80 (Damsky 
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et al.,  1983; Wheelock et al.,  1987), E-cadherin (Yoshida- 
Noro et al.,  1984), N-cadherin (Hatta and Takeichi,  1986), 
P-cadherin  (Nose and Takeichi,  1986),  N-caI-CAM  (Bixby 
et al.,  1987),  A-CAM (Volk and Geiger,  1984),  and Arc-1 
(Behrens  et al.,  1985). 
Recently,  the modification  of proteins by covalently  at- 
tached lipids has captured the interest of many investigators 
(for review see Sefton and Buss, 1987). Some proteins have 
a  covalently  attached  glycosyl-phosphatidylinositol  moiety 
that serves to anchor the polypeptide portion of the molecule 
to the cell surface lipid bilayer (for reviews see Low, 1987; 
Cross, 1987; Low and Saltiel,  1988; Ferguson and Williams, 
1988).  Included in this group of proteins are two cell-cell 
adhesion molecules that can be anchored to the cell surface 
via the phosphatidylinositol-glycan  moiety-the Ca÷+-inde  - 
pendent neural cell adhesion  molecule, N-CAM (Hemperly 
et al., 1986; He et al., 1986), and the lymphocyte LFA-3 cell 
adhesion glycoprotein (Dustin et al., 1987). N-CAM, a mem- 
ber of the immunoglobulin family (Cunningham,  1986; Cun- 
ningham et al., 1987), is expressed by muscle cells (Grumet 
et al., 1982; Rutishauser  et al., 1983), has a muscle-specific 
sequence in the extracellular  domain in human muscle cells 
(Dickson et al.,  1987),  undergoes changes  in its isoforms 
during myogenesis (Moore et al., 1987), is found at the neu- 
romuscular junction (Reiger et al., 1985), and is thought  to 
mediate  neuromuscular  interaction  (Grumet et al.,  1982; 
Rutishauser  et al.,  1983;  for review  see Edelman,  1983). 
Thy-1 antigen  is another glycosyl-phosphatidylinositol-an- 
©  The Rockefeller University Press, 0021-9525/89/10/1779/8 $2.00 
The Journal of Cell Biology, Volume 109, October 1989  1779-1786  1779 chored protein (Homans et al.,  1988; also see Low,  1987; 
Cross, 1987; Low and Saltiel, 1988; Ferguson and Williams, 
1988) expressed by rodent muscle during myogenesis (Les- 
ley and Lennon, 1977), but it does not appear to play a role 
in myoblast fusion (Schweitzer et al., 1987). The extracellu- 
lar domain of the above phosphatidylinositol-anchored pro- 
teins can be released from cells by treatment with phospha- 
tidylinositol-specific phospholipase C  (PI-PLC)  ~ (for review 
see Low,  1987). 
Some years ago Nameroff et al. (1973) demonstrated that 
treating muscle cell cultures with phospholipase C  (PLC) 
from Clostridium welchii inhibited the fusion of myoblasts. 
The authors speculated that PLC treatment altered the sur- 
face of myoblasts in  a  way  that prevented the  cells from 
recognizing each other. In a later publication Nameroff and 
Munar  (1976)  reported  that  PLC-treated  myoblasts  con- 
tinued to line up on the culture dish, even though they did 
not fuse. The authors interpreted this to mean that myoblast 
recognition and fusion were separate events and that PLC in- 
hibited myoblast fusion but not cell-cell recognition. 
In the studies reported here we investigated the effect of PI- 
PLC on cell-cell adhesion of fusion-competent chick em- 
bryo myoblasts. 
Materials and Methods 
Materials 
PLC (type III from Bacillus cereus) and o-myo-inositol I-monophosphate 
OPt) were purchased from Sigma Chemical Co. (St.  Louis, MO). Purified 
PI-PLC from Bacillus thuringiensis was a gift of Martin Low (College of 
Physicians and Surgeons of Columbia University, New York) or was pur- 
chased from ICN Biomedicals, Inc. (Cleveland, OH). Neuraminidase (type 
X from Clostridium perfringens) was purchased from Sigma Chemical Co. 
Calcium-free DME was made in our laboratory or purchased from Hazelton 
Research Products (Lenexa, KS) and DME with calcium was purchased 
from Flow Laboratories,  Inc.  (McLean,  VA).  FCS  was from HyClone 
Laboratories (Logan, UT). Embryo extract was made by expressing decapi- 
tated, eviscerated ll-d chick embryos through a syringe, adding a twofold 
volume excess of Ca++-free  10 mM Hepes-buffered Hanks' balanced salt 
solution (HHBSS), and extracting the tissue material on ice for 30 min fol- 
lowed by centrifugation and recovery of the supernate. Afli-Gel 10 was from 
Bio-Rad Laboratories (Richmond, CA), lectins were from E. Y. Laborato- 
ries, Inc. (San Mateo, CA), alkaline phosphatase-coupled antibodies were 
from Kirkegaard & Perry Laboratories, Inc. (Gaithersburg, MD), and other 
reagents were from Sigma Chemical Co. 
Antibodies 
The antiserum to fusion-competent myoblasts (anti-myo) was generated by 
injecting a rabbit with fusion-blocked, 52-h, CSAT-harvested myoblasts as 
described (Knudsen, 1985).  Anti-myo inhibits both myoblast adhesion and 
myotube formation (Knudsen, 1985).  Antisera to PI-PLC-released glyco- 
proteins were generated by injecting mice intraperitoneally three times at 
2-wk intervals with 100/~1 of Affi-Gel 10-immobilized Lens culinaris lectin 
(Knudsen et al., 1981) that had been exposed to material released by PI-PLC 
(B.  cereus)  from 5-10  x  106 cells and then washed free of nonabsorbed 
material. Cell-derived protein was estimated to be ,~1-5/zg/injection. Con- 
trol mice were injected with similar volumes of inactivated Afli-Gel 10, lec- 
tin conjugated to AtTi-Gel 10, and PLC (Sigma Chemical Co.) (5-10/~g/in- 
jection). CSAT is a monoclonal antibody that binds to avian integrins (Neff 
et al., 1982).  Specific, polyclonal rabbit antiserum to chicken N-CAM was 
a girl from Drs. M. Watanabe and U. Rutishauser (Case Western Reserve 
University School of Medicine, Cleveland, OH). 
1.  Abbreviations  used  in  this  paper:  anti-myo,  antiserum  to  fusion- 
competent myoblasts; HHBSS, 10 mM Hepes-buffered Hanks' balanced salt 
solution;  IPt,  tr-myo-inositol  l-monophosphate; PI-PLC,  phosphatidyli- 
nositol-specific phospholipase C; PLC, phospholipase C. 
Cell Culture 
Primary cultures of  pectoral skeletal muscle cells and chick fibroblasts were 
prepared from ll-d chick embryos as described (Knudsen and Horwitz, 
1977).  To enrich cultures for myoblasts, the cells wore routinely preplated 
on non-gelatin-coated culture dishes for 2-4 h. When indicated, a second 
24-h preplate on gelatin-coated dishes was done to yield cultures highly en- 
riched for myoblasts. By 72 h, these cultures incorporated 90% of  the nuclei 
into myotubes in the presence of Ca  ++. Myoblast cultures were grown in 
Ca++-free  DME plus 10% FCS and, when indicated, 5% embryo extract. 
EGTA was added during the first 24 h to achieve a final concentration that 
prevented myotube formation but did not disturb cell-substratum adhesion 
(i.e., "~65 ~M). Under these conditions, the cultures displayed a maximal 
ability to form myotubes at  ,'~52 h  culture age (Knudsen and Horwitz, 
1977). Therefore, fusion-competent myoblasts are defined as fusion-blocked, 
52-h-old cells. 
Myoblasts were harvested either by pipette or by the addition of CSAT 
monoclonal antibody (Neff et al.,  1982)  which recognizes CSAT-antigen 
(Neff et al., 1982; Knudsen et al., 1985), an integrin-glycoprotein  complex 
involved in ceU-substratum adhesion (for review see Buck and Horwitz, 
1987). CSAT binds to both myoblasts and fibroblasts; however, the antibody 
predominantly perturbs the adhesion of the myoblasts and thus permits the 
collection of a population of cells highly enriched in myoblasts (Neff et al., 
1982;  Knudsen, 1985).  While the addition of CSAT to muscle cultures at 
the time of initial  plating has been shown by Menko and Bocttiger (1987) 
to inhibit myogenic differentiation, addition of the antibody to 52-h cells has 
no effect on myoblast fusion (Neff et al.,  1982)  or my~blast interaction 
(Knudsen,  1985). 
Myoblast Aggregation 
Aggregation of fusion-competent myoblasts was performed essentially as 
described (Knudsen and Horwitz,  1977).  Briefly,  52-h, fusion-competent 
myoblasts grown in low Ca  ++ medium were harvested, washed once, and 
mixed in suspension at a concentration of 3-5  x  105 cells/ml for 18 min 
at 37°C in serum-free HHBSS in the presence of either 1 mM EGTA or 1.5 
mM Ca  ++. 
Using the above nonenzymatic methods of  harvesting cells, the myoblasts 
presumably expressed both  Ca++-independent and -dependent adhesion 
mechanisms since they aggregated in both the absence and presence of 
Ca  ++.  However, in the presence of Ca++ both the number of cells in ag- 
gregates and the size of aggregates were larger than in the absence of Ca  ++ 
Thus,  under our conditions, aggregation in the presence of Ca++ can be 
considered to result from a combination of Ca++-independent and -depen- 
dent mechanisms. 
Aggregation was scored microscopically by counting cells as described 
(Knudsen and Horwitz, 1977).  Aggregation increased with time (Knudsen 
and Horwitz, 1977),  but after ,x,20 min the aggregates in the presence of 
Ca  ++ became too large to accurately score the number of cells in an aggre- 
gate. Therefore, the assay was routinely terminated after 18 min. The values 
for percent aggregation varied somewhat from day to day, perhaps due to 
variation in the cell concentration or, possibly, to the differentiation state 
of the cells: i.e., the number of the myoblasts expressing the aggregation- 
and fusion-competent phenotype. The Ca++-independent and -dependent 
aggregation varied in concert, however; that is, if the percent aggregation 
in the presence of Ca  ++ was high, so was the percent aggregation in its ab- 
sence. (Note that for unknown reasons that may have to do with embryos 
from a different flock and/or FCS from a different lot, we recently have had 
to include embryo extracts in the cell culture medium to achieve good myo- 
tube formation. Using cells grown under these conditions, we noted that 
longer exposure to PI-PLC (30-60 min) was required to see an inhibitory 
effect on myoblast aggregation.) 
Myoblast Fusion 
Myoblast fusion was initiated by the addition of 1.5 mM Ca  ++ to 52-h cul- 
tures grown in low Ca  ++ medium. In the studies presented here, fusion was 
scored qualitatively by microscopic examination of the cultures for the pres- 
ence of multinucleate myotubes and the results were recorded photographi- 
cally. 
SDS-PAGE 
SDS-PAGE of NP-40 extracts or immunopreeipitates was performed under 
reducing conditions as described by Laemmli (1970).  The acrylamide con- 
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cluded myosin (205 kD), beta-galactosidase  (116 kD), phosphorylase b (97 
kD), BSA (66 kD), ovalbumin (43 kD), and carbonic anhydrase (30 kD). 
When indicated, cell supernates or cell extracts were exposed to 1 U/ml 
neuraminidase (C. perfringens)  in sodium acetate buffer, pH 5.5, for 30 min 
at 3"/°C to remove sialic acid residues from proteins before SDS-PAGE. 
lmmunoblot Analysis of Cell Extracts 
Immunoblot studies were performed according to Towbin et al. (1979) and 
Burnette (I  981) except that enzyme-coupled antibodies and dyes were used 
to detect antigen. Similar numbers of cells (e.g., myoblasts  and fibroblasts 
and control and PI-PLC-treated cells) were harvested by scraping and ex- 
tracted with 0.5% NP-40 nonionic detergent as described (Knudsen et ai., 
1981). Extracted proteins were resolved by SDS-PAGE, transferred elec- 
trophoretically to nitrocellulose, incubated with 3 % BSA to block nonspe- 
cific protein-binding  sites, exposed  to first antibody (i.e., pooled mouse anti- 
sera to PLC-released glycoproteins  or rabbit anti-N-CAM), and developed 
with the appropriate alkaline phosphatase-conjugated  second antibody.  The 
substrates included both nitro blue tetrazolium and 5-bromo-4-chloro-3- 
indoyi phosphate. 
Results 
The Effect of PLC  from B. cereus 
on Myotube Formation 
To determine whether or not PI-PLC treatment affected myo- 
tube formation we removed the medium from 52-h cultures 
grown in low Ca  ÷÷ medium containing  10%  FCS,  exposed 
the cells to PLC from B.  cereus  (Sigma Chemical Co.) for 
10 min at 37°C, removed the enzyme, returned the medium 
to the cells, and added 1.5 mM Ca  ++ to initiate myoblast fu- 
sion. Control cultures were treated similarly except that no 
enzyme was added.  Exposure to PLC had a  noticeable in- 
hibitory effect on  myotube formation observed 20 h  later. 
Control cultures in Ca++-repleted medium formed large mul- 
tinucleate myotubes (Fig.  1 A), while PLC-treated cultures 
in  Ca÷÷-repleted medium  formed  no  large  myotubes  and 
looked more similar to cultures in low Ca++ medium (Fig. 
1, C and B, respectively). Exposure to PLC under the above 
conditions had no noticeable effect on cell-substratum adhe- 
sion, suggesting that the effect of the enzyme was not due to 
contaminating protease activity. In addition, the lack of any 
obvious effect on cell-matrix adhesion suggested that the in- 
hibition of myotube  formation was  not due  to  generalized 
membrane perturbations by PLC. 
Exposure to PLC did not appear to be toxic since the PLC- 
treated myoblasts formed large myotubes and looked similar 
to Ca++-repleted control cultures after an additional 24 h  in 
culture (Fig.  1, E  and D,  respectively). Taken together the 
results suggested that PLC had a  specific, nontoxic, and re- 
versible effect on cell surface events involved in myoblast fu- 
sion. However, because the formation of myotubes in culture 
Figure L The effect of PLC on myotube for- 
mation.  Myoblast cultures were prepared 
from ll-d chick embryos and grown in low 
Ca  ++ DME plus  10%  FCS for 52  h.  The 
medium was  removed and  the cells were 
treated with PLC (2 U/ml; Sigma Chemical 
Co.)  in  Ca++-free  HHBSS  for  10  min  at 
37°C.  The enzyme was then removed, the 
conditioned medium returned, and 1.5 mM 
Ca++ added to initiate fusion. Control cells 
were treated similarly except that the en- 
zyme was omitted. 20 (A-C) or 44 h later 
(D and E), the cells were fixed, stained, and 
photographed. (A and D) Control cells in 
the presence of Ca++. (B) Control cells in 
the absence of Ca++. (C and E) PLC-treated 
cells in the presence of Ca  ~. Bar, 200 ~,m. 
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adhesion,  and lipid bilayer union and because the enzyme 
preparation might affect more than one aspect of myoblast 
fusion, we decided to focus our studies on the effect of PLC 
on the intercellular adhesion of fusion-competent myoblasts. 
The Effect of  PLC  from B. cereus on 
Myoblast-Myoblast Adhesion 
We  investigated  the  possibility  that  PI-PLC  treatment  of 
fusion-competent myoblasts perturbed the cell-cell adhesion 
step of myotube formation. 52-h, fusion-blocked chick myo- 
blasts were harvested with CSAT antibody, washed, adjusted 
to a concentration of 3-5  ×  106 cells/ml, exposed to PLC 
(B. cereus) forl0 min at 37°C, and then diluted 10-fold with 
HHBSS to minimize the enzyme's activity during the subse- 
quent aggregation assay. Control cells were treated similarly 
except that the enzyme was omitted. The aggregation assay 
was performed by mixing cells in  suspension (3-5  ×  105 
cells/ml) in the presence or absence of Ca  ++ for 18 min at 
37°C and scoring the extent of aggregation by counting cells 
using a phase-contrast microscope. 
Treatment of fusion-competent myoblasts with PLC from 
B. cereus inhibited myoblast aggregation in a dose-dependent 
manner (Fig. 2). The enzyme's effect appeared to be maximal 
at a PLC concentration of ,ol-2 U/ml. It is to be noted that 
myoblast aggregation was not completely inhibited. Increas- 
ing the enzyme concentration to 10 U/ml resulted in a some- 
what  greater  inhibition  of myoblast aggregation  but  also 
resulted in membrane damage to an increasing number of 
cells,  as indicated by the cells' inability to exclude trypan 
blue dye. At no enzyme concentration was the effect of the 
PLC on myoblast aggregation altered by the addition of pro- 
tease inhibitors  such as serum, soy bean trypsin inhibitor, 
leupeptin,  or PMSE  however,  indicating  that the enzyme 
effect, even at high concentrations, was not likely due to pro- 
tease activity in the PLC preparation. 
The effect of PLC treatment on myoblast adhesion  was 
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Figure 2. The effect of PLC on cell-cell adhesion of fusion-com- 
petent myoblasts. Myoblast cultures were prepared from ll-d chick 
embryo pectoral muscle and grown in low Ca  ++ DME plus  10% 
FCS for 52 h. Myoblasts were harvested with CSAT, adjusted to a 
concentration of 3-5  ×  106 cells/ml,  and exposed to various con- 
centrations of PLC from B. cereus (type III; Sigma Chemical Co.) 
for l0 min at 37°C as described  in Materials  and Methods.  The 
mixture was then diluted 1:10 in HHBSS and the aggregation assay 
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Figure 3. The effect of PLC on cell-cell adhesion of fusion-com- 
petent myoblasts in the presence of IP~. Muscle cultures were pre- 
pared from ll-d chick embryo pectoral muscle and grown in Ca  ++- 
free DME plus 10% FCS for 51 h. The myoblasts were harvested 
with CSAT monoclonal antibody, adjusted to a concentration of 3-5 
×  106 ceUs/ml, and treated  with various concentrations  of PLC 
from B. cereus (type III; Sigma Chemical Co.) in the presence of 
various concentrations  of IP~. The PLC and IPi  were mixed to- 
gether before adding the cells and incubating the mixture for 10 min 
at 37°C. The mixture was then diluted 1:10 and the aggregation as- 
say was performed  as described  in Materials and Methods. 
incubation  with  the enzyme before the  aggregation assay. 
However, if the myoblasts were permitted to form aggregates 
in the presence of Ca  ++ for  18 min before adding  the en- 
zyme, PLC was unable to dissociate the aggregated cells, 
suggesting  that  some  event(s)  occurred  that  resulted  in 
cell-cell adhesion no longer being susceptible to the action 
of PLC. This result further suggested that the enzyme activ- 
ity was not likely due to protease contamination since, after 
18 min, the myoblast aggregates can be dispersed by trypsin 
(Knudsen and Horwitz,  1977). 
Specificity of the Effect of  PI-PLC on Myoblast 
Adhesion 
Two lines of evidence suggested that the adhesion of fusion- 
competent myoblasts was inhibited specifically by the activ- 
Table L The Effect of  PI-PLC on Cell-Cell Adhesion of 
Fusion-competent Myoblasts 
Treatment  Ca  ++  Aggregation  Ca  ++ control* 
ram  %  % 
Control  -  9  +  1¢  37 
Control  1.5  24  +  2  100 
PI-PLC  -  5  +  2¢  21 
PI-PLC  1.5  13  +  3¢  54 
Fusion-competent myoblasts were harvested with CSAT after growing the cells 
in low Ca  ++ medium for 52 h. Cells at a concentration of 3-5  x  106 cells/ml 
were treated in Ca++-free  HHBSS  for  10 min at 37°C with 3  U/ml  PI-PLC 
purified from culture supernatants of B. thuringiensis (gift of M. Low). Con- 
trol cells were treated similarly except that no enzyme was added. The mixture 
was diluted  1:10 with HHBSS  and the aggregation assay was performed as 
described in Materials and Methods.  The  percentage of aggregation at time 
zero was 2 % and was subtracted from the percent aggregation at the end of the 
assay, The enzyme had an inhibitory effect on aggregation at concentrations as 
low as 0,3 U/ml but was no more effective at inhibiting aggregation at 30 U/ml 
than at 3  U/ml. 
* Calculated by dividing the percent aggregation in the treatment population 
by the percent aggregation of control ceils in the presence of Ca  ++ (5: SD). 
$ Significantly different from the Ca  ++ control by t test (p  =  <  .01,  n  =  4), 
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hibitory effect of the PLC from R  cereus on myoblast aggre- 
gation in a dose-dependent fashion (Fig. 3). IP~ alone had 
no effect on myoblast aggregation. Secondly, a highly puri- 
fied preparation of PI-PLC (gift of M. l.x~) isolated from 
R  thuringiensis  also inhibited myoblast adhesion (Table I) 
(Low et al.,  1988). 
PI-PLC from R  thuringiensis  (and from R  cereus)  in- 
hibited the aggregation of myoblasts occurring in either the 
absence or presence of Ca  ++ (Table I). The effect of the en- 
zyme on myoblast aggregation in the presence of Ca  ÷÷- 
which  in  our  system  presumably  includes  both  Ca  ÷÷- 
independent and -dependent mechanisms (see Aggregation 
Assay in Materials and Methods)-did not appear to be due 
solely to the enzyme's effect on the Ca**-independent sys- 
tem. That is, an inhibitory effect on aggregation in the pres- 
ence of Ca  ÷÷ (Ca  ÷÷ independent plus dependent) by PI-PLC 
was noted even when aggregation in the absence of Ca  ÷÷ 
was mathematically subtracted from aggregation in the pres- 
ence  of Ca  ÷÷  (Table  I).  Like PLC  from R  cereus,  PLC 
from B.  thuringiensis  did not completely abolish myoblast 
adhesion even when the enzyme concentration was increased 
10-fold to 30 U/ml. The enzyme from B. thuringiensis had 
no effect on the cells' ability to exclude trypan blue even at 
incubation times up to 60 min or at high concentrations (i.e., 
30 U/ml). Lastly, PI-PLC treatment similarly inhibited the 
aggregation of myoblasts regardless of whether the cells were 
harvested by pipette or with CSAT antibody. 
Evidence that Treating Fusion-competent Myoblasts 
with PI-PLC Released Adhesion-related Glycoproteins 
into the Supernate 
We postulated that PI-PLC acted by releasing a form of cell 
surface glycoproteins involved in the adhesion of fusion- 
competent myoblasts rather than by nonspecifically perturb- 
ing the myoblast surface. The detection and identification of 
the released form(s) of myoblast adhesion molecules was 
therefore of interest. Whereas we speculated that the adhe- 
sion molecules in material released from fusion-competent 
myoblasts by PI-PLC might directly perturb cell-cell adhe- 
sion of the myoblasts, we observed no significant effect on 
cell aggregation when PLC-released material from 10 times 
the number of cells present in the assay was added to ag- 
gregating cells. This might have resulted from a number of 
complications, including insufficient soluble adhesion-related 
glycoproteins or a loss of  physiological (i.e., adhesion) activ- 
ity of  the PLC-released molecules. Since the possibilities ap- 
peared difficult to approach experimentally, we turned to in- 
direct methods to detect the presence of adhesion-related 
molecules in the material released from myoblasts by PI-PLC. 
First, we assayed for the presence of  adhesion-related mol- 
ecules by using a  competitive immunoassay and observed 
that material released by PI-PLC was able to inhibit the effect 
of anti-myo antiserum previously shown to perturb myoblast 
aggregation (Knudsen,  1985)  (Table  II).  This result sug- 
gested that antigen in the material released by PI-PLC neu- 
tralized the effect of adhesion-perturbing antibodies in anti- 
myo antiserum, which presumably inhibited myoblast ag- 
gregation by binding to  molecules on the  surface of the 
myoblasts involved in adhesion. 
Secondly, we assayed for the presence of adhesion-related 
molecules in PLC-released material by testing its ability to 
generate  adhesion-perturbing  antisera.  To  minimize  the 
amount of PLC in the material to be injected into animals we 
prepared a glycoprotein fraction from the material released 
by PI-PLC as the immunogen. Using this approach we ob- 
served  that  glycoproteins  in  the  PLC-released  material 
stimulated adhesion-inhibiting antisera when injected into 
mice (Table HI). To generate these antisera we found we had 
to immunize mice with immobilized L. culinaris lectin that 
had been exposed to material released by PI-PLC and washed 
free of nonabsorbed material as described in Materials and 
Methods. Not surprisingly the antisera also contained anti- 
bodies to L. culinaris lectin and PLC, as detected by immu- 
noblot analysis (data not shown).  However, antisera from 
mice injected with Affi-Gel 10, lectin-conjugated Affi-Gel 
10, or PLC had no effect on myoblast aggregation (data not 
shown). We took the approach of immunizing mice in this 
way because we were unable to efficiently elute material 
bound to the lectin, suggesting that glycoproteins in the PLC- 
released material had a high affinity for the lectin, which may 
not be surprising considering that myoblast adhesion-related 
molecules are glycosylated  at asparagine-linked sites (Knud- 
Table II. Effect of  Material Released  from 
Fusion-competent Myoblasts with PLC on the 
Adhesion-inhibiting  Activity of  an Antiserum to Myoblasts 
Treatment  Aggregation  Control* 
%  % 
Preimmune serum  34  100 
Anti-myo  15  44 
Anti-myo  +  PLC  +  IP~  14  41 
Anti-myo  +  PLC-R  +  IPt  35  103 
Anti-myo is an adhesion-inhibiting  antiserum that was generated by injecting 
a rabbit with fusion-competent  myoblasts and has been described  previously 
(Knudsen,  1985). Preimmune  serum and anti-myo were used at a dilution of 
1:30.  IP~  (4 raM) was added to prevent  PLC  from acting on the  myoblasts 
during  the  aggregation  assay.  PLC-released  material  (PLC-R) was from 10 
times the number  of ceils in the assay. The values reported for percent aggrega- 
tion represent the average of duplicates that varied from the mean by <15%. 
All assays were performed  in the presence of 1.5  mM added Ca  ++. 
* Calculated  by dividing  percent  aggregation  in the  treatment  group by the 
percent aggregation  in the presence  of preimmune  serum. 
Table IlL The Effect on Myoblast Aggregation of 
Mouse Antisera to Glycoproteins Released by PLC  from 
Fusion-competent Myoblasts 
Treatment  Ca  +*  Aggregation  Ca  ++ control 
mM  %  % 
Control  -  12  36 
Control  1.5  33  100 
Preimmune serum  1.5  38  115 
Anti-PLC-R (GP)  1.5  16  48 
The mice were immunized with glycoproteins  released  by PLC  (B. cereus) 
from fusion-competent  myoblasts and absorbed  on immobilized L.  culinaris 
lectin as described in Materials and Methods.  Preimmune  serum and antisera 
to  PLC-released  glycopruteins  (anti-PLC-R[GP])  were used  at  dilutions  of 
1:30.  The  aggregation  assay  was performed  as described  in Materials  and 
Methods. The numbers reported for percent aggregation for controls and pre- 
immune serum groups represent the average of two numbers that varied from 
the mean by <18%. The number for percent aggregation of the group treated 
with antisera to PLC-released glycoproteins represents the average of four dif- 
ferent antisera  that varied from the mean by <20%. 
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phosphatidylinositol-anchored proteins. 
Antigens Expressed by Fusion-competent Myoblasts 
That are Recognized by the Mouse Antisera to 
PLC-released Glycoproteins 
To  probe  for candidate  adhesion  molecules  expressed  by 
fusion-competent myoblasts, detergent extracts of  chick cells 
were  immunoblotted with pooled adhesion-perturbing  an- 
tisera to the PLC-released glycoprotein fraction from fusion- 
competent myoblasts.  Six to eight bands  in the molecular 
mass region of 116,000 to >200,000 D, with a major band at 
140 kD,  were observed in the extract of fusion-competent 
myoblasts but were not observed in the extract of fibroblasts 
(Fig.  4). Simlar bands were detected in immunoprecipitates 
of NP-40 extracts of ~25I-surface labeled,  fusion-competent 
myoblasts (data not shown). The antisera did not appear to 
be  entirely  muscle  specific,  however,  since  they  also de- 
tected material in the extract of fibroblasts. This was not sur- 
prising since considerable protein was shed from myoblasts 
in  suspension in the absence of PI-PLC and some of this 
likely represented glycoproteins expressed by chicken cells 
other  than  myoblasts.  Nevertheless,  the  immunoblot data 
using  antisera  to  the  PLC-released  glycoprotein fraction 
from fusion-competent suggested that the bands of interest 
as candidates for myoblast adhesion molecules were in the 
molecular mass region of 116-200 kD. 
The Relationship of  the PI-PLC-released Molecules 
to Other Known Phosphatidylinositol-anchored 
Adhesion Molecules 
We were interested  in knowing whether the molecules re- 
leased by PI-PLC from the fusion-competent myoblasts were 
related to any other known phosphatidylinositol-linked pro- 
teins. We focused on N-CAM for a number of reasons. First, 
N-CAM is known to have an isoform linked to the cell sur- 
face membrane via glycosyl-phosphatidylinositol. Second, 
N-CAM mediates cell-cell adhesion by virtue of its ability 
Figure  5. Immunoblot of  the supernate and cell extract of  myoblasts 
treated with PI-PLC using anti-N-CAM. Muscle cultures were pre- 
pared from the pectoral muscle of lid embryos, transferred at 2 
and 24 h to enrich for myoblasts, and grown (7.5 x  106 cells/well 
in a 6-well dish; Costar, Cambridge, MA) in Ca++-free DME plus 
10% FCS and 5 % embryo extract until the cells were 52 h old. The 
medium was removed, the cells were washed, DME (700/~l/well) 
containing 3 U/ml PI-PLC (B.  thuringiensis; ICN Biomedieals, 
Inc.) was added to two wells, and the ceils were incubated for 1 h 
at 37°C. After the incubation period, the supernate was collected, 
pooled, centrifuged to remove debris, and concentrated fourfold to 
increase the protein concentration. The cells were washed, scraped, 
pooled, pelleted by centrifugation, and extracted with 0.5 % NP-40 
(120 #l/cell pellet). Two wells of control cells were treated identi- 
cally except that the enzyme was omitted. Half of  the supernate and 
detergent extract from control and PI-PLC-treated cells was treated 
with neuraminidase to remove sialic acid from the protein. Similar 
volumes of concentrated supernate (30 t~l) and cell extract (30/~1) 
from control and  PI-PLC-treated  cells were resolved by SDS- 
PAGE, transferred electrophoretically to nitrocellulose, and probed 
with rabbit polyclonal IgG (1/zg/ml) to N-CAM (gift from M. Wa- 
tanabe and U. Rutishauser). The protein concentration of control 
and PI-PLC cell extract was 5.9 and 2.6 mg/ml, respectively, while 
the protein concentration in the supernates was below the level of 
detection. (Lane A) Neuraminidase-treated control supernate; (lane 
B) control supernate; (lane C) neuraminidase-treated PI-PLC su- 
pernate; (lane D) PI-PLC supernate; (lane E) neuraminidase-treated 
control cell extract; (lane F) control cell extract; (lane G) neurami- 
nidase-treated PI-PLC-treated cell extract; and (lane H) PI-PLC 
cell extract. 
Figure 4. Immunoblot analysis of detergent 
extracts of myoblasts and fibroblasts using 
antisera to glycoproteins released from fu- 
sion-competent  myoblasts by  PLC  from 
B.  cereus. Muscle cultures were prepared 
from  l l-d  chick  embryo pectoral muscle 
and grown for 51 h in Ca++-free DME plus 
10% FCS. Fibroblasts were prepared from 
the skin of ll-d embryos, grown in DME 
plus 10% FCS, and passaged twice before 
harvesting. The ceils were washed free of 
serum, harvested by scraping, and extracted 
with 0.5% NP-40. The extracts were ad- 
justed to a similar protein concentration and 
'~30 #g of protein from each cell type was 
resolved by SDS-PAGE, transferred elec- 
trophoretically to  nitrocellulose,  and  im- 
munoblotted with a 1:50 dilution of pooled 
mouse antisera to PLC-released glycoproteins. (Lane A) Molecular 
mass standards including myosin (205 kD), beta-galactosidase (116 
kD),  phosphorylase b  (97  kD),  and BSA (66 kD) stained with 
Coomassie blue; (lane B) myoblast  extract; and (lane C) fibroblast 
extract. 
to self-associate (i.e., N-CAM on one cell binds to N-CAM 
on an adjacent cell). Lastly, N-CAM is expressed by muscle 
as multiple polysialylated isoforms with molecular masses in 
the region of the bands detected in myoblasts by our antisera 
to PLC-released glycoproteins. 
Fig. 5 shows that N-CAM was present in the supernate of 
PI-PLC-treated fusion-competent myoblasts, but not in the 
supernate of control cells.  Neuraminidase treatment of the 
supernate to remove sialic acid residues from N-CAM before 
immunoblot analysis caused N-CAM to migrate as a single 
band with a molecular mass of •120,000  D, instead of as a 
smear with molecular masses  from  120 to >205 kD.  The 
120-kD desialo N-CAM band was greatly reduced in the neur- 
aminidase-treated  detergent extract of the  PI-PLC-treated 
cells when compared with the extract of control cells, indi- 
cating that this isoform of N-CAM was released by PI-PLC 
and, therefore,  linked to the surface of fusion-competent myo- 
blasts via phosphatidylinositol. One other major desialo iso- 
form of N-CAM was detected in the extract of the cells, but 
not in the supernate of PI-PLC-treated cells.  This N-CAM 
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membrane peptide domain and likely explains why PI-PLC 
did not completely inhibit myoblast interaction even in the 
absence of Ca  +÷. Both major desialo isoforms of N-CAM, 
including the 120-kD lipid-linked form, were detected in the 
detergent extract of control myoblasts not treated with PI-PLC. 
Discussion 
The data presented here suggest that a portion of the glyco- 
proteins involved in the formation of myotubes is linked to 
the cell surface lipid bilayer through a phosphatidylinositol 
anchorage.  Cell-cell,  but  not  cell-matrix,  adhesion  of 
fusion-competent myoblasts was  inhibited by treating the 
cells with PI-PLC. The effect of the enzyme appeared to be 
specific, nontoxic, reversible, and not due to contaminating 
protease activity. While inhibition of myotube formation by 
PLC from B.  cereus (Sigma Chemical Co.) may have re- 
sulted from the inhibition of myoblast-myoblast adhesion, 
the enzyme preparation  used in these studies could have 
affected another step in myotube formation, such as lipid 
bilayer union. 
PI-PLC treatment of fusion-competent myoblasts inhibited 
cell-cell adhesion in both the absence and presence of Ca  ++ 
in our system and appeared to have an inhibitory effect on 
both the Ca÷÷-independent  and -dependent aspects of myo- 
blast adhesion. The enzyme appeared  to act by releasing 
adhesion-related glycoproteins from the surface of fusion- 
competent myoblasts since such molecules were detected in- 
directly by (a) the ability of PLC-released material to block 
the effect of an adhesion-perturbing antiserum to intact myo- 
blasts; and (b) the ability of PLC-released glycoproteins to 
stimulate adhesion-perturbing antisera when injected into 
mice. 
Myoblast adhesion was inhibited only partially by PI-PLC 
treatment of the cells, suggesting that only a portion of the 
molecules mediating myoblast interaction is linked to the 
myoblast surface via phosphatidylinositol. This might be ex- 
plained in  several ways.  First,  PI-PLC-resistant adhesion 
could involve PI-PLC-insensitive isoforms of the PI-PLC- 
releasable adhesion molecule, as is the case with N-CAM. 
Alternatively, the PI-PLC-resistant myoblast adhesion might 
involve peptide-anchored molecules biochemicaUy unrelated 
to the PI-PLC-releasable adhesion glycoprotein. Most like- 
ly, myoblast interaction involves a combination of the two 
scenarios, especially when Ca  ++ is present. 
PI-PLC released an isoform of N-CAM from the surface of 
fusion-competent  myoblasts. Assuming that our antisera to PI- 
PLC-released glycoproteins included antibodies to N-CAM, 
it is understandable that this antisera recognized multiple 
bands of  molecular masses 116-200 kD in the extract of myo- 
blasts  since N-CAM  is  expressed  in polysialylated forms 
with molecular masses ranging from 120 kD to much higher 
than 200 kD in chicken muscle (Rutishauser et al.,  1983). 
Our observation that fusion-competent myoblasts express 
a lipid-linked isoform of N-CAM is consistent with those of 
Moore et al. (1987) and Barton et al. (1988) demonstrating 
phosphatidylinositol-linked forms of N-CAM in mouse and 
human muscle cells, respectively. A role for N-CAM in neu- 
romuscular interactions has been demonstrated (Grumet et 
al., 1982;  Rutishauser et al., 1983),  but a role for N-CAM 
in myogenesis has only been postulated. Our results suggest 
a role for N-CAM in the cell-cell adhesion step of myotube 
formation. N-CAM  self-associates in the absence of Ca  ++ 
(Edelman et al., 1987) and is expressed by chick muscle cells 
(Grumet et al.,  1982;  Rutishauser et al.,  1983),  making it 
possible  that  N-CAM  participates  in  myoblast-myoblast 
adhesion and is likely the predominant, or only, adhesion 
mechanism mediating myoblast interaction in the absence of 
Ca  ++ . In support of this hypothesis, experiments conducted 
in our lab (Knudsen, K. A., S. A. McElwee, and L. Myers, 
manuscript submitted for publication) show that antibodies 
to N-CAM inhibit myoblast interaction. 
The inhibitory effect of PI-PLC on Ca++-dependent,  as 
well as Ca++-independent, adhesion may result directly from 
the release of an as yet unidentified lipid-linked Ca++-de- 
pendent adhesion molecule(s) from the myoblast surface. 
Alternatively, the  PI-PLC effect on Ca++-dependent  myo- 
blast adhesion may be indirect and reflect the result of a loss 
of N-CAM molecules on the Ca++-dependent adhesion mech- 
anism. The latter interpretation is supported by the observa- 
tions of Rutishauser et al. (1988) which indicate N-CAM can 
influence cell-ceU interaction mediated by other mechanisms. 
The  physiological significance of the  inositol phospho- 
lipid-anchored N-CAM in myogenesis is not understood at 
this time. The significance of such a lipid anchorage has been 
speculated on for other proteins, however (see Low, 1987; 
Low and Saltiel. 1988; Sefton and Buss, 1987; Cross, 1987; 
Ferguson and Williams, 1988).  The glycosyl-phosphatidyl- 
inositol moiety might simply serve to anchor the protein to 
the lipid bilayer or might confer on the protein unique prop- 
erties. For instance, an increased lateral mobility might play 
a role in the protein's function. In addition, the protein por- 
tion of the molecule might be released by an endogenous 
PLC, resulting in consequences such as termination of a cell 
surface event, rapid production of cell polarity, or release of 
1,2-diacylglycerol, a  known activator of protein kinase C 
(Nishizuka,  1986). 
In the presence of Ca  ++, when both Ca+÷-independent and 
-dependent adhesion mechanisms are intact (as in the in vivo 
situation and in our in vitro system), N-CAM most likely 
functions in combination with a  Ca+÷-dependent  adhesion 
molecule(s) that is likely a member of the cadherin family. 
Together,  N-CAM and the Ca÷+-dependent  adhesion mole- 
cule(s) function to mediate myoblast recognition and adhe- 
sion during myogenesis. 
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